[In the Media] NCD Alliance Japan: How is COVID-19 affecting people living with NCDs?
date : 4/24/2020
Tags: NCDs
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus in 2019. With the spread of COVID-19 infections all over the world, the impact of COVID-19 on people living with non-communicable diseases (NCDs) including cancer, diabetes, cardiovascular diseases, chronic respiratory disease, mental health has been reported.
- The evidence from multiple countries at the epicentre of the pandemic clearly shows that people living with NCDs are more vulnerable to COVID-19. According to a study, the overall death rate from COVID-19 has been estimated at 0.66%, rising sharply to 7.8% in people aged over 80. *1
- Diabetes, cardiovascular disease, and chronic respiratory disease are the most common underlying diseases of hospitalized patients infected with COVID-19. It has also been pointed out that risk factors common to NCDs, such as smoking, are one of the factors that may aggravate COVID-19. World Health Organization warns that smokers likely face more severe symptoms if infected, leading to hospitalizations and premature deaths.
- Due to the limitation of daily life from self-quarantine and self-isolation, people living with NCDs are more likely to face difficulties with controlling their symptoms and taking medication as they may refrain from going to medical institutions because of fear of COVID-19 infection, and tend to have more stress than healthy people.
- NCDs involve many social determinants such as poverty and education. These social determinants of health are also obstacles to containment of COVID-19, and it is necessary to cultivate awareness and build a foundation for tackling it throughout society.
NCD Alliance Japan, a collaborative platform for civil society operated by Health Global Policy Institute, will do our best to raise our voices for the rights of people living with NCDs, older people and marginalised groups, and to collate and share information useful for COVID-19 infection prevention and control through a NCDs lens.
WHO: Information note on COVID-19 and NCDs (Published 23 March 2020)
https://www.who.int/who-documents-detail/covid-19-and-ncds
For more information about the NCD Alliance Japan, please visit us here:
https://ncdjapan.org/en/
*1: Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020 Mar 30
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D



